MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge.
Ontology highlight
ABSTRACT: Rett syndrome is a severe and progressive neurological disorder linked to mutations in the MeCP2 gene. It has been suggested that immune alterations may play an active role in the generation and/or maintenance of RTT phenotypes. However, there is no clear consensus about which pathways are regulated in vivo by MeCP2 in the context of immune activation. In the present work we set to characterize the role of MeCP2 during the progression of Experimental Autoimmune Encephalomyelitis (EAE) using the MeCP2308/y mouse model (MUT), which represents a condition of "MeCP2 function deficiency". Our results showed that MeCP2 deficiency increased the susceptibility to develop EAE, along with a defective induction of anti-inflammatory responses and an exacerbated MOG-specific IFNγ expression
SUBMITTER: Zalosnik MI
PROVIDER: S-EPMC8155097 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
ACCESS DATA